Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Salinger, David H.
244  Ergebnisse:
Personensuche X
?
1

Recommendation of mavacamten posology by model‐based analys..:

Merali, Samira ; Salinger, David H. ; Palmisano, Maria...
CPT: Pharmacometrics & Systems Pharmacology.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

An Exposure-Response Perspective on the Clinical Dose of Pr..:

Nedelman, Jerry R. ; Salinger, David H. ; Subramoney, Vishak...
Antimicrobial Agents and Chemotherapy.  65 (2020)  1 - p. , 2020
Link: https://doi.org/10.1128/..
 
?
3

Long-Term Effects on QT Prolongation of Pretomanid Alone an..:

Li, Hanbin ; Salinger, David H. ; Everitt, Daniel...
Antimicrobial Agents and Chemotherapy.  63 (2019)  10 - p. , 2019
Link: https://doi.org/10.1128/..
 
?
4

Daily Dosing for Bedaquiline in Patients with Tuberculosis:

Salinger, David H. ; Nedelman, Jerry R. ; Mendel, Carl..
Antimicrobial Agents and Chemotherapy.  63 (2019)  11 - p. , 2019
Link: https://doi.org/10.1128/..
 
?
5

Population Pharmacokinetics of the Antituberculosis Agent P..:

Salinger, David H. ; Subramoney, Vishak ; Everitt, Daniel.
Antimicrobial Agents and Chemotherapy.  63 (2019)  10 - p. , 2019
Link: https://doi.org/10.1128/..
 
?
6

Population pharmacokinetics of brodalumab in healthy adults..:

Endres, Christopher J. ; Salinger, David H. ; Köck, Kathleen...
The Journal of Clinical Pharmacology.  54 (2014)  11 - p. 1230-1238 , 2014
Link: https://doi.org/10.1002/..
 
?
7

Prediction of clinical pharmacokinetics of AMG 181, a human..:

Li, Hong ; Köck, Kathleen ; Wisler, John A....
Pharmacology Research & Perspectives.  3 (2014)  1 - p. , 2014
Link: https://doi.org/10.1002/..
 
?
8

A semi‐mechanistic model to characterize the pharmacokineti..:

Salinger, David H. ; Endres, Christopher J. ; Martin, David A..
Clinical Pharmacology in Drug Development.  3 (2014)  4 - p. 276-283 , 2014
Link: https://doi.org/10.1002/..
 
?
9

Population pharmacokinetic/dynamic model of lymphosuppressi..:

McCune, Jeannine S. ; Vicini, Paolo ; Salinger, David H....
Cancer Chemotherapy and Pharmacology.  75 (2014)  1 - p. 67-75 , 2014
Link: https://doi.org/10.1007/..
 
?
10

A Limited Sampling Schedule to Estimate Mycophenolic Acid A..:

Li, Hong ; Mager, Donald E. ; Bemer, Meagan J....
The Journal of Clinical Pharmacology.  52 (2012)  11 - p. 1654-1664 , 2012
Link: https://doi.org/10.1177/..
 
?
11

Quantitative Prediction of Human Pharmacokinetics for Monoc..:

Dong, Jennifer Q. ; Salinger, David H. ; Endres, Christopher J....
Clinical Pharmacokinetics.  50 (2011)  2 - p. 131-142 , 2011
Link: https://doi.org/10.2165/..
 
?
12

Measurement of Human Surfactant Protein-B Turnover in Vivo ..:

Tomazela, Daniela M. ; Patterson, Bruce W. ; Hanson, Elizabeth...
Analytical Chemistry.  82 (2010)  6 - p. 2561-2567 , 2010
Link: https://doi.org/10.1021/..
 
?
13

Development of a Population Pharmacokinetics‐Based Sampling..:

Salinger, David H. ; Vicini, Paolo ; Blough, David K....
The Journal of Clinical Pharmacology.  50 (2010)  11 - p. 1292-1300 , 2010
Link: https://doi.org/10.1177/..
 
?
14

Pharmacogenomic trial design: use of a PK/PD model to explo..:

Salinger, David H. ; Shen, Danny D. ; Thummel, Kenneth...
Pharmacogenetics and Genomics.  19 (2009)  12 - p. 965-971 , 2009
Link: https://doi.org/10.1097/..
 
?
15

Population Pharmacokinetics of Cyclophosphamide and Metabol..:

McCune, Jeannine S. ; Salinger, David H. ; Vicini, Paolo...
The Journal of Clinical Pharmacology.  49 (2009)  1 - p. 88-102 , 2009
Link: https://doi.org/10.1177/..
 
1-15
Mehr Literatur finden
Jerome D. Salinger